Amoy Diagnostics Co., Ltd. (300685.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Amoy Diagnostics Co., Ltd.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1144
First IPO Date
August 03, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Frank Ron Zheng | Deputy GM & Director | 0 | 1990 |
| Hongyu Wang | Deputy General Manager | 0 | 1984 |
| Huibin Zheng | Deputy General Manager | 0 | 1962 |
| Jiemin Luo | GM & Director | 0 | 1983 |
| Ruan Li | Deputy GM, Chief Technology Officer & Director | 0 | 1978 |
| Ying Chen | Chief Financial Officer, Accounting Supervisor & Secretary to the Board of Directors | 0 | 1970 |
AD
Description
Amoy Diagnostics Co., Ltd. is a diagnostics company focused on molecular diagnostic solutions for precision oncology. Operating both within China and across international markets, the firm provides a range of sophisticated assays, including Next-Generation Sequencing (NGS), real-time PCR, Fluorescence In Situ Hybridization (FISH), and various extraction methods. Established in 2008, Amoy Diagnostics has its base in Xiamen, China.
AD
